Back to Search
Start Over
New Drugs 2016 PART 3.
- Source :
-
Nursing . Sep2016, Vol. 46 Issue 9, p34-43. 10p. - Publication Year :
- 2016
-
Abstract
- The article offers information about drugs approved by the U.S. Food and Drug Administration (FDA) as of September 2016, including Eluxadoline with brand name Viberzi from pharmaceutical company Allergan, Rolapitant hydrochloride with brand name Varubi from pharmaceutical company Tesaro, and Cangrelor with brand name Kengreal from The Medicines Company.
- Subjects :
- *THERAPEUTIC use of monoclonal antibodies
*DRUG therapy for asthma
*ADIPOSE tissues
*ALKALINE phosphatase
*ANTINEOPLASTIC agents
*ANTIEMETICS
*CANCER chemotherapy
*COMBINATION drug therapy
*CHIN
*CYSTIC fibrosis
*DRUG interactions
*DRUG monitoring
*DRUGS
*DRUG administration
*DOSAGE forms of drugs
*ESTERASES
*GENETIC techniques
*IMIDAZOLES
*IRRITABLE colon
*MONOCLONAL antibodies
*MYOCARDIAL revascularization
*PATIENT education
*RARE diseases
*PLASTIC surgery
*TRANSLUMINAL angioplasty
*CONTINUING education units
*PLATELET aggregation inhibitors
*NURSING interventions
*PHARMACODYNAMICS
*THERAPEUTICS
Subjects
Details
- Language :
- English
- ISSN :
- 03604039
- Volume :
- 46
- Issue :
- 9
- Database :
- Academic Search Index
- Journal :
- Nursing
- Publication Type :
- Academic Journal
- Accession number :
- 118099134
- Full Text :
- https://doi.org/10.1097/01.NURSE.0000490206.28060.7d